ZWHC:CA:TSX-BMO Covered Call Health Care ETF (CAD)

ETF | Others |

Last Closing

CAD 30.15

Change

-0.40 (-1.31)%

Market Cap

N/A

Volume

665.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-02-10 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XEQT:CA iShares Core Equity Portfolio

+0.31 (+0.89%)

CAD 6.64B
XEF-U:CA iShares Core MSCI EAFE IMI Ind..

+0.06 (+0.22%)

CAD 6.19B
CASH:CA GLOBAL X HIGH INTEREST SAVINGS..

+0.01 (+0.02%)

CAD 5.91B
PHYS-U:CA Sprott Physical Gold Trust

+0.26 (+1.17%)

CAD 4.76B
XUS-U:CA iShares Core S&P 500 Index ETF

+0.26 (+0.69%)

CAD 4.54B
HXT-U:CA Global X S&P/TSX 60 Index ETF

+0.39 (+0.84%)

CAD 3.92B
CEF-U:CA Sprott Physical Gold and Silve..

+0.29 (+1.10%)

CAD 3.78B
PSLV-U:CA Sprott Physical Silver Trust

+0.01 (+0.09%)

CAD 3.29B
ZMMK:CA BMO Money Market Fund ETF Seri..

-0.01 (-0.02%)

CAD 3.24B
NSCB:CA NBI Sustainable Canadian Bond ..

-0.18 (-0.78%)

CAD 2.78B

ETFs Containing ZWHC:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 4.54% 84% B 77% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 4.54% 84% B 77% C+
Trailing 12 Months  
Capital Gain 3.04% 21% F 26% F
Dividend Return 4.92% 81% B- 73% C
Total Return 7.96% 30% F 31% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 2.04% 42% F 40% F
Dividend Return 2.77% 43% F 34% F
Total Return 0.73% 80% B- 35% F
Risk Return Profile  
Volatility (Standard Deviation) 4.55% 84% B 93% A
Risk Adjusted Return 60.94% 73% C 70% C-
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.